Malaysia is taking a bold step towards a healthier future with a new initiative aimed at tackling noncommunicable diseases (NCDs). This collaborative effort by the Ministry of Health Malaysia (MOH), the World Health Organization (WHO), and the United Nations InterAgency Task Force on Non Communicable Diseases (UNIATF), promises not only to improve public health but also to enhance economic prosperity. On 19 November 2024, the MOH, in collaboration with WHO and UNIATF, unveiled a comprehensive investment case in the Malaysian Parliament.
The report, titled "Prevention and Control of Noncommunicable Diseases in Malaysia: The Case for Investment," reveals the staggering economic burden of NCDs, amounting to RM 64.2 billion or 4.2% of the GDP in 2021. This includes RM 12.4 billion in public healthcare costs and RM 51.8 billion in productivity losses.
NCDs, like cardiovascular disease, diabetes, and cancer, are more than just health issues—they contribute to significant economic burdens in Malaysia, with premature deaths and reduced productivity affecting our economic progress. The findings in the report underscore the urgent need to escalate strategic investments in prevention and control measures.
A Vision for Preventive Healthcare
YB Datuk Seri Dr Dzulkefly Ahmad, Minister of Health Malaysia, emphasizes the shift towards preventive healthcare during the launch of the NCD investment case report
YB Datuk Seri Dr Dzulkefly Ahmad, Minister of Health Malaysia, emphasized the need for a shift in healthcare strategy. "We must move from a curative approach to one that is preventive, promotive and predictive. Our healthcare transformation agenda prioritizes preventive public health. This investment case identifies the most effective and cost-efficient policies to safeguard our nation's health while driving economic prosperity," he said.
The report provides a detailed analysis of the current NCD landscape and offers actionable recommendations to improve health outcomes and economic stability. This includes several cost-effective policies targeting key NCD risk factors, such as reducing salt and tobacco consumption, promoting physical activity, and increasing cancer screening. For example, the salt reduction package is expected to yield RM 60.1 for every RM 1 invested, while the tobacco control package could return RM 5.9 for every RM 1 invested.
A Roadmap for Policymakers
Dr. Rabindra Abeyasinghe, WHO Representative, highlights the economic and health benefits of strategic investments in NCD prevention and control
Dr. Rabindra Abeyasinghe, WHO Representative to Malaysia, Brunei Darussalam, and Singapore, highlighted the potential benefits of strategic investments. "With collaborative efforts to promote healthy lifestyles and prevent NCDs, we can significantly reduce their impact, improve quality of life, and strengthen the economy. This investment case provides a clear roadmap for action," he said.
The investment case offers a detailed plan for policymakers, healthcare providers, and stakeholders. It emphasizes the need for multi-sectoral collaboration and a whole-of-system approach to address NCDs. The report also highlights the potential to save over 180,000 lives and recover RM 30 billion in economic output over the next 15 years.
"The Ministry of Health Malaysia is dedicated to implementing these recommendations. By prioritizing NCD prevention and control, we can ensure a healthier, more prosperous future for all Malaysians," concluded Dr Dzulkefly Ahmad.
Ready to dive into the details and be part of this transformative journey? Download the full investment report now and discover how we can create a healthier, more prosperous Malaysia together!